Full-Time

Commercial Excellence Manager

Posted on 4/10/2025

Insulet Corporation

Insulet Corporation

1,001-5,000 employees

No salary listed

Senior, Expert

London, UK

The position can be remote, hybrid or in-person at our offices in London or Utrecht. Travel is estimated at 20% but will flex depending on business need.

Category
Project Management
Strategy Development
Business & Strategy
Required Skills
Tableau
Salesforce
Data Analysis
Requirements
  • Excellent analytical and project management skills
  • Ability to challenge and collaborate at all levels of the organization within and outside of direct team
  • Ability to mentor and coach individuals and teams to achieve optimal performance
  • Knowledge of the medical device / diabetes market and its reimbursement are a plus
  • Ability to conduct sophisticated and creative analysis of complex problems
  • Strong communication skills, self-organization, hands-on mentality, and pragmatism are necessary qualities for a successful job
  • Strong command of English language (verbal and written); German, Dutch and/French are a plus
  • Exceptional computer skills. Must be proficient in Microsoft Office 365
  • Knowledge of Salesforce Lightning/Tableau, Microsoft or SAP HANA is an advantage
Responsibilities
  • Identify opportunities to streamline, improve and automate commercial processes, to ensure maximum efficiency
  • Contribute to or lead the development of commercial strategies to profitably maintain/grow accounts in line with Insulet International's business strategy. This includes developing new business opportunities for additional direct markets
  • Identify further improvement opportunities for existing markets to deliver sustainable business growth
  • Develop a framework to present opportunities and expected outcomes for management review and prioritisation
  • Define standard reports/dashboards to drive efficient management decisions and enable data-driven insights & analytics providing actionable insights to commercial teams
  • Ensure consistent work systems and processes and their KPI-based control
  • Manage the effective implementation of CRM/ERP system improvements and process optimisation to ensure seamless customer acquisition and retention, working closely with all necessary departments such as IT and relevant stakeholders
  • Facilitate collaboration and communication between various departments including sales, marketing, finance, etc.
  • Champion and facilitate any organisational changes using change management methods and present the results to senior management
  • Develop and implement efficient and standardised processes to enable the organisation to adopt new ways of working and procedures
  • Provide tools & instruments to enable the organisation to manage the new processes based on KPIs. This includes training on how to use them appropriately
  • Ensure that appropriate resources and skills are in place to deliver the required continuous improvement culture throughout the new processes
  • Create a transparent communication structure
  • Establish a platform for the structured organisation and management of actions
  • Creating a culture that is open to change (empowering employees to identify, name, report and implement problems)
  • Sharing best practice and transferring experience to the relevant departments
Desired Qualifications
  • BS/BA degree; MBA a plus and/or equivalent combination of education and experience
  • Relevant experience typically working as a Project Manager, Commercial Excellence Manager, Business or Strategy Consultant, (potentially) Program Manager or in FP&A with a Commercial background
  • Relevant experience gained working within Medtech - in Diabetes a plus, Pharma, Business Consulting/Strategic Management
  • Experience in working in a cross-functionally and matrix environment
  • Passion in dealing with new technologies for digitalization and automation is assumed
  • Experience in setting up and developing structures and processes

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Acton, Massachusetts

Founded

2000

Simplify Jobs

Simplify's Take

What believers are saying

  • Insulet raised $444.4M to optimize capital structure and support growth.
  • Omnipod 5's expansion into five European countries boosts international presence.
  • Winning $452M in a trade secrets trial strengthens Insulet's financial position.

What critics are saying

  • Emerging diabetes care companies may challenge Insulet's market share.
  • Technological advancements require continuous R&D investment to stay competitive.
  • Supply chain vulnerabilities in semiconductor components could disrupt production.

What makes Insulet Corporation unique

  • Insulet leads in tubeless insulin pump technology with its Omnipod brand.
  • The Omnipod 5 integrates with Dexcom G7 CGM, enhancing diabetes management.
  • Insulet's multinational RADIANT trial showcases innovation in transitioning from daily injections.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Financial Modeling Prep
Mar 28th, 2025
Insulet Corporation's Financial Efficiency in the Medical Device Industry

Insulet competes with companies like DexCom, Tandem Diabetes Care, and Masimo Corporation in the diabetes care market.

Stock Titan
Mar 18th, 2025
Insulet Secures $450M Through Senior Notes Offering: Key Details on Strategic Debt Refinancing

Insulet raises $444.4M through senior notes to refinance existing convertible debt. Strategic move positions medical device maker for future growth while optimizing capital structure.

Stock Titan
Mar 18th, 2025
From Injections to Innovation - Insulet to Present Results from a Multinational Randomized Trial of Direct Transition from Multiple Daily Injections to Omnipod(R) 5 in Adults and Children with Type 1 Diabetes

Insulet (NASDAQ: PODD) will present results from its multinational RADIANT trial at the 18th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in March 2025.

Path8 Video
Mar 11th, 2025
Insulet product launch video

This video helped Insulet launch its new iPhone app.

Financial Modeling Prep
Mar 6th, 2025
Ubiquiti Inc. (NYSE:UI) Outshines Peers in Capital Efficiency

Ubiquiti competes with companies like Fair Isaac Corporation, Paylocity Holding Corporation, Monolithic Power Systems, EPAM Systems, and Insulet Corporation.